BioGX manufacture of custom-designed, platform agnostic Sample-Ready™ reagents for Laboratory Developed Tests (USA only). Using real-time PCR, BioGX makes molecular testing easy for labs with its novel Sample-Ready™ approach to LDTs, which enable a lab to specify its choice of test and receive a high-performance mix of all the necessary reagents, primers and probes, lyophilized and in one tube without the need for refrigeration. The proprietary Sample-Ready™ technology is at the core of the company’s worldwide offerings across clinical, food safety, pharma and water quality testing.

Wholly owned subsidiary, BioGX BV, has a large portfolio of CE-IVD marked tests, spread across a wide variety of infectious diseases ranging from COVID-19, respiratory to sexual health, enteric pathogens, drug resistance, meningitis, transplant and tropical disease.